Bulk Manufacturer of Controlled Substances Application: Chemtos, LLC, 36937-36941 [2019-16176]
Download as PDF
<![CDATA[
36937
Federal Register / Vol. 84, No. 146 / Tuesday, July 30, 2019 / Notices
stated above and submit 8 true paper
copies to the Office of the Secretary by
noon the next day pursuant to
Commission Rule 210.4(f), 19 CFR
210.4(f). Submissions should refer to the
investigation number (‘‘Inv. No. 1098’’)
in a prominent place on the cover page
and/or the first page. (See Handbook for
Electronic Filing Procedures, https://
www.usitc.gov/secretary/documents/
handbook_on_filing_procedures.pdf).
Persons with questions regarding filing
should contact the Secretary, (202) 205–
2000.
Any person desiring to submit a
document to the Commission in
confidence must request confidential
treatment. All such requests should be
directed to the Secretary to the
Commission and must include a full
statement of the reasons why the
Commission should grant such
treatment. See 19 CFR 201.6. Documents
for which confidential treatment by the
Commission is properly sought will be
treated accordingly. All information,
including confidential business
information and documents for which
confidential treatment is properly
sought, submitted to the Commission for
purposes of this Investigation may be
disclosed to and used: (i) by the
Commission, its employees and Offices,
and contract personnel (a) for
developing or maintaining the records
of this or a related proceeding, or (b) in
internal investigations, audits, reviews,
and evaluations relating to the
programs, personnel, and operations of
the Commission including under 5
U.S.C. Appendix 3; or (ii) by U.S.
government employees and contract
personnel, solely for cybersecurity
purposes. All contract personnel will
sign appropriate nondisclosure
agreements. All nonconfidential written
submissions will be available for public
inspection at the Office of the Secretary
and on EDIS.
The authority for the Commission’s
determination is contained in section
337 of the Tariff Act of 1930, as
amended (19 U.S.C. 1337), and in Part
210 of the Commission’s Rules of
Practice and Procedure (19 CFR part
210).
By order of the Commission.
Issued: July 24, 2019.
Katherine Hiner,
Supervisory Attorney.
[FR Doc. 2019–16151 Filed 7–29–19; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: Chemtos,
LLC
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before September 30, 2019.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152.
DATES:
In
accordance with 21 CFR 1301.33(a), this
is notice that on May 15, 2019, Chemtos,
LLC, 16713 Picadilly Court, Round
Rock, Texas 78664–8544 applied to be
registered as a bulk manufacturer of the
following basic classes of controlled
substances:
SUPPLEMENTARY INFORMATION:
jspears on DSK3GMQ082PROD with NOTICES
Controlled substance
Drug code
3-Fluoro-N-methylcathinone (3–FMC) .......................................................................................................................
Cathinone ..................................................................................................................................................................
Methcathinone ...........................................................................................................................................................
4-Fluoro-N-methylcathinone (4–FMC) .......................................................................................................................
Pentedrone (a-methylaminovalerophenone) .............................................................................................................
Mephedrone (4-Methyl-N-methylcathinone) ..............................................................................................................
4-Methyl-N-ethylcathinone (4–MEC) .........................................................................................................................
Naphyrone .................................................................................................................................................................
N-Ethylamphetamine .................................................................................................................................................
N,N-Dimethylamphetamine .......................................................................................................................................
Fenethylline ...............................................................................................................................................................
Aminorex ...................................................................................................................................................................
4-Methylaminorex (cis isomer) ..................................................................................................................................
Gamma Hydroxybutyric Acid .....................................................................................................................................
Methaqualone ............................................................................................................................................................
Mecloqualone ............................................................................................................................................................
JWH–250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) ............................................................................................
SR–18 (Also known as RCS–8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole) .........................................
ADB–FUBINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) ......
5-Fluoro-UR–144 and XLR11 [1-(5-Fluoro-pentyl)1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone ..........
AB–FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) ...............
JWH–019 (1-Hexyl-3-(1-naphthoyl)indole) ................................................................................................................
MDMB–FUBINACA (Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) ................
AB–PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) ...................................
THJ–2201 [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone .............................................................
AB–CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide ..........
MAB–CHMINACA (N-(1-amino-3,3dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) ..
5F–AMB (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate) ........................................
5F–ADB; 5F–MDMB–PINACA (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate)
ADB–PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) ...........................
MDMB–CHMICA,
MMB–CHMINACA
(Methyl
2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3dimethylbutanoate).
APINACA and AKB48 N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide ........................................................
5F–APINACA, 5F–AKB48 (N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide) ............................
JWH–081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole) ............................................................................................
SR–19 (Also known as RCS–4) (1-Pentyl-3-[(4-methoxy)-benzoyl] indole ..............................................................
JWH–018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) .......................................................................
JWH–122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole) ...............................................................................................
VerDate Sep<11>2014
16:42 Jul 29, 2019
Jkt 247001
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
E:\FR\FM\30JYN1.SGM
30JYN1
Schedule
1233
1235
1237
1238
1246
1248
1249
1258
1475
1480
1503
1585
1590
2010
2565
2572
6250
7008
7010
7011
7012
7019
7020
7023
7024
7031
7032
7033
7034
7035
7042
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
7048
7049
7081
7104
7118
7122
I
I
I
I
I
I
36938
Federal Register / Vol. 84, No. 146 / Tuesday, July 30, 2019 / Notices
jspears on DSK3GMQ082PROD with NOTICES
Controlled substance
Drug code
UR–144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone ...........................................................
JWH–073 (1-Butyl-3-(1-naphthoyl)indole) .................................................................................................................
JWH–200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole) ....................................................................................
AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole) .................................................................................................
JWH–203 (1-Pentyl-3-(2-chlorophenylacetyl) indole) ...............................................................................................
PB–22 (Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate) ...........................................................................................
5F–PB–22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate) ......................................................................
Alpha-ethyltryptamine ................................................................................................................................................
Ibogaine .....................................................................................................................................................................
CP–47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) ..........................................................
CP–47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol) ....................................
Lysergic acid diethylamide ........................................................................................................................................
2,5-Dimethoxy-4-(n)-propylthiophenethylamine (2C–T–7) ........................................................................................
Marihuana Extract .....................................................................................................................................................
Marihuana .................................................................................................................................................................
Parahexyl ..................................................................................................................................................................
Mescaline ..................................................................................................................................................................
2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine (2C–T–2 ) ....................................................................................
3,4,5-Trimethoxyamphetamine ..................................................................................................................................
4-Bromo-2,5-dimethoxyamphetamine .......................................................................................................................
4-Bromo-2,5-dimethoxyphenethylamine ....................................................................................................................
4-Methyl-2,5-dimethoxyamphetamine .......................................................................................................................
2,5-Dimethoxyamphetamine ......................................................................................................................................
JWH–398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole) ...............................................................................................
2,5-Dimethoxy-4-ethylamphetamine ..........................................................................................................................
3,4-Methylenedioxyamphetamine ..............................................................................................................................
5-Methoxy-3,4-methylenedioxyamphetamine ............................................................................................................
N-Hydroxy-3,4-methylenedioxyamphetamine ...........................................................................................................
3,4-Methylenedioxy-N-ethylamphetamine .................................................................................................................
3,4-Methylenedioxymethamphetamine ......................................................................................................................
4-Methoxyamphetamine ............................................................................................................................................
5-Methoxy-N-N-dimethyltryptamine ...........................................................................................................................
Alpha-methyltryptamine .............................................................................................................................................
Bufotenine .................................................................................................................................................................
Diethyltryptamine .......................................................................................................................................................
Dimethyltryptamine ....................................................................................................................................................
Psilocybin ..................................................................................................................................................................
Psilocyn .....................................................................................................................................................................
5-Methoxy-N,N-diisopropyltryptamine .......................................................................................................................
N-Ethyl-1-phenylcyclohexylamine .............................................................................................................................
1-(1-Phenylcyclohexyl)pyrrolidine ..............................................................................................................................
1-[1-(2-Thienyl)cyclohexyl]piperidine .........................................................................................................................
1-[1-(2-Thienyl)cyclohexyl]pyrrolidine ........................................................................................................................
N-Ethyl-3-piperidyl benzilate .....................................................................................................................................
N-Methyl-3-piperidyl benzilate ...................................................................................................................................
N-Benzylpiperazine ...................................................................................................................................................
4-Methyl-alphapyrrolidinopropiophenone (4-MePPP) ...............................................................................................
2-(2,5-Dimethoxy-4-methylphenyl) ethanamine (2C–D) ...........................................................................................
2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine (2C–E ) .............................................................................................
2-(2,5-Dimethoxyphenyl) ethanamine (2C–H) ..........................................................................................................
2-(4-iodo-2,5-dimethoxyphenyl) ethanamine (2C–I) .................................................................................................
2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine (2C–C) ............................................................................................
2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine (2C–N) ..............................................................................................
2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine (2C–P) .......................................................................................
2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine (2C–T–4) .............................................................................
MDPV (3,4-Methylenedioxypyrovalerone) .................................................................................................................
2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25B–NBOMe) ..............................................
2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25C–NBOMe) ..............................................
2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25I–NBOMe) ...................................................
Methylone (3,4-Methylenedioxy-N-methylcathinone) ................................................................................................
Butylone ....................................................................................................................................................................
Pentylone ..................................................................................................................................................................
alpha-pyrrolidinopentiophenone (a-PVP) ..................................................................................................................
alpha-pyrrolidinobutiophenone (a-PBP) ....................................................................................................................
AM–694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole) .............................................................................................
Acetyldihydrocodeine ................................................................................................................................................
Benzylmorphine .........................................................................................................................................................
Codeine-N-oxide .......................................................................................................................................................
Cyprenorphine ...........................................................................................................................................................
Desomorphine ...........................................................................................................................................................
Etorphine (except HCl) ..............................................................................................................................................
Codeine methylbromide ............................................................................................................................................
Dihydromorphine .......................................................................................................................................................
Difenoxin ...................................................................................................................................................................
VerDate Sep<11>2014
16:42 Jul 29, 2019
Jkt 247001
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
E:\FR\FM\30JYN1.SGM
30JYN1
7144
7173
7200
7201
7203
7222
7225
7249
7260
7297
7298
7315
7348
7350
7360
7374
7381
7385
7390
7391
7392
7395
7396
7398
7399
7400
7401
7402
7404
7405
7411
7431
7432
7433
7434
7435
7437
7438
7439
7455
7458
7470
7473
7482
7484
7493
7498
7508
7509
7517
7518
7519
7521
7524
7532
7535
7536
7537
7538
7540
7541
7542
7545
7546
7694
9051
9052
9053
9054
9055
9056
9070
9145
9168
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
36939
Federal Register / Vol. 84, No. 146 / Tuesday, July 30, 2019 / Notices
jspears on DSK3GMQ082PROD with NOTICES
Controlled substance
Drug code
Heroin ........................................................................................................................................................................
Hydromorphinol .........................................................................................................................................................
Methyldesorphine ......................................................................................................................................................
Methyldihydromorphine .............................................................................................................................................
Morphine methylbromide ...........................................................................................................................................
Morphine methylsulfonate .........................................................................................................................................
Morphine-N-oxide ......................................................................................................................................................
Myrophine ..................................................................................................................................................................
Nicocodeine ...............................................................................................................................................................
Nicomorphine ............................................................................................................................................................
Normorphine ..............................................................................................................................................................
Pholcodine .................................................................................................................................................................
Thebacon ..................................................................................................................................................................
Acetorphine ...............................................................................................................................................................
Drotebanol .................................................................................................................................................................
U–47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide) ........................................................
AH–7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide)) ...........................................................
Acetylmethadol ..........................................................................................................................................................
Allylprodine ................................................................................................................................................................
Alphacetylmethadol except levo-alphacetylmethadol ...............................................................................................
Alphameprodine ........................................................................................................................................................
Alphamethadol ..........................................................................................................................................................
Benzethidine ..............................................................................................................................................................
Betacetylmethadol .....................................................................................................................................................
Betameprodine ..........................................................................................................................................................
Betamethadol ............................................................................................................................................................
Betaprodine ...............................................................................................................................................................
Clonitazene ...............................................................................................................................................................
Dextromoramide ........................................................................................................................................................
Diampromide .............................................................................................................................................................
Diethylthiambutene ....................................................................................................................................................
Dimenoxadol .............................................................................................................................................................
Dimepheptanol ..........................................................................................................................................................
Dimethylthiambutene .................................................................................................................................................
Dioxaphetyl butyrate .................................................................................................................................................
Dipipanone ................................................................................................................................................................
Ethylmethylthiambutene ............................................................................................................................................
Etonitazene ...............................................................................................................................................................
Etoxeridine ................................................................................................................................................................
Furethidine ................................................................................................................................................................
Hydroxypethidine .......................................................................................................................................................
Ketobemidone ...........................................................................................................................................................
Levomoramide ...........................................................................................................................................................
Levophenacylmorphan ..............................................................................................................................................
Morpheridine .............................................................................................................................................................
Noracymethadol ........................................................................................................................................................
Norlevorphanol ..........................................................................................................................................................
Normethadone ...........................................................................................................................................................
Norpipanone ..............................................................................................................................................................
Phenadoxone ............................................................................................................................................................
Phenampromide ........................................................................................................................................................
Phenoperidine ...........................................................................................................................................................
Piritramide .................................................................................................................................................................
Proheptazine .............................................................................................................................................................
Properidine ................................................................................................................................................................
Racemoramide ..........................................................................................................................................................
Trimeperidine ............................................................................................................................................................
Phenomorphan ..........................................................................................................................................................
Propiram ....................................................................................................................................................................
1-Methyl-4-phenyl-4-propionoxypiperidine ................................................................................................................
1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine ........................................................................................................
Tilidine .......................................................................................................................................................................
Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide) ...........................................................................
Para-Fluorofentanyl ...................................................................................................................................................
3-Methylfentanyl ........................................................................................................................................................
Alpha-methylfentanyl .................................................................................................................................................
Acetyl-alpha-methylfentanyl ......................................................................................................................................
Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) ........................................................................
Butyryl Fentanyl ........................................................................................................................................................
4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide) ..................................
Beta-hydroxyfentanyl .................................................................................................................................................
Beta-hydroxy-3-methylfentanyl ..................................................................................................................................
Alpha-methylthiofentanyl ...........................................................................................................................................
3-Methylthiofentanyl ..................................................................................................................................................
VerDate Sep<11>2014
16:42 Jul 29, 2019
Jkt 247001
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
E:\FR\FM\30JYN1.SGM
30JYN1
9200
9301
9302
9304
9305
9306
9307
9308
9309
9312
9313
9314
9315
9319
9335
9547
9551
9601
9602
9603
9604
9605
9606
9607
9608
9609
9611
9612
9613
9615
9616
9617
9618
9619
9621
9622
9623
9624
9625
9626
9627
9628
9629
9631
9632
9633
9634
9635
9636
9637
9638
9641
9642
9643
9644
9645
9646
9647
9649
9661
9663
9750
9811
9812
9813
9814
9815
9821
9822
9824
9830
9831
9832
9833
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
36940
Federal Register / Vol. 84, No. 146 / Tuesday, July 30, 2019 / Notices
Controlled substance
Drug code
jspears on DSK3GMQ082PROD with NOTICES
Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide) .......................................................
Thiofentanyl ...............................................................................................................................................................
Beta-hydroxythiofentanyl ...........................................................................................................................................
Amphetamine ............................................................................................................................................................
Methamphetamine .....................................................................................................................................................
Lisdexamfetamine .....................................................................................................................................................
Phenmetrazine ..........................................................................................................................................................
Methylphenidate ........................................................................................................................................................
Amobarbital ...............................................................................................................................................................
Pentobarbital .............................................................................................................................................................
Secobarbital ..............................................................................................................................................................
Glutethimide ..............................................................................................................................................................
Nabilone ....................................................................................................................................................................
1-Phenylcyclohexylamine ..........................................................................................................................................
Phencyclidine ............................................................................................................................................................
4-Anilino-N-phenethyl-4-piperidine (ANPP) ...............................................................................................................
Phenylacetone ...........................................................................................................................................................
1-Piperidinocyclohexanecarbonitrile ..........................................................................................................................
Alphaprodine .............................................................................................................................................................
Anileridine ..................................................................................................................................................................
Cocaine .....................................................................................................................................................................
Codeine .....................................................................................................................................................................
Etorphine HCl ............................................................................................................................................................
Dihydrocodeine .........................................................................................................................................................
Oxycodone ................................................................................................................................................................
Hydromorphone .........................................................................................................................................................
Diphenoxylate ............................................................................................................................................................
Ecgonine ...................................................................................................................................................................
Ethylmorphine ...........................................................................................................................................................
Hydrocodone .............................................................................................................................................................
Levomethorphan .......................................................................................................................................................
Levorphanol ...............................................................................................................................................................
Isomethadone ............................................................................................................................................................
Meperidine .................................................................................................................................................................
Meperidine intermediate-A ........................................................................................................................................
Meperidine intermediate-B ........................................................................................................................................
Meperidine intermediate-C ........................................................................................................................................
Methadone ................................................................................................................................................................
Methadone intermediate ...........................................................................................................................................
Metopon ....................................................................................................................................................................
Dextropropoxyphene, bulk (non-dosage forms) ........................................................................................................
Morphine ...................................................................................................................................................................
Thebaine ...................................................................................................................................................................
Dihydroetorphine .......................................................................................................................................................
Levo-alphacetylmethadol ..........................................................................................................................................
Oxymorphone ............................................................................................................................................................
Noroxymorphone .......................................................................................................................................................
Phenazocine ..............................................................................................................................................................
Thiafentanil ................................................................................................................................................................
Piminodine .................................................................................................................................................................
Racemethorphan .......................................................................................................................................................
Racemorphan ............................................................................................................................................................
Alfentanil ....................................................................................................................................................................
Remifentanil ..............................................................................................................................................................
Sufentanil ..................................................................................................................................................................
Carfentanil .................................................................................................................................................................
Tapentadol ................................................................................................................................................................
Bezitramide ...............................................................................................................................................................
Fentanyl .....................................................................................................................................................................
Moramide-intermediate .............................................................................................................................................
VerDate Sep<11>2014
16:42 Jul 29, 2019
Jkt 247001
PO 00000
Frm 00057
Fmt 4703
Sfmt 9990
E:\FR\FM\30JYN1.SGM
30JYN1
9834
9835
9836
1100
1105
1205
1631
1724
2125
2270
2315
2550
7379
7460
7471
8333
8501
8603
9010
9020
9041
9050
9059
9120
9143
9150
9170
9180
9190
9193
9210
9220
9226
9230
9232
9233
9234
9250
9254
9260
9273
9300
9333
9334
9648
9652
9668
9715
9729
9730
9732
9733
9737
9739
9740
9743
9780
9800
9801
9802
Schedule
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
36941
Federal Register / Vol. 84, No. 146 / Tuesday, July 30, 2019 / Notices
The company plans to manufacture
small quantities of the listed controlled
substances in bulk for distribution to its
customers.
Dated: July 16, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019–16176 Filed 7–29–19; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
In
accordance with 21 CFR 1301.34(a), this
is notice that on May 8, 2019, Alcami
Carolinas Corporation, 1726 North 23rd
Street, Wilmington, North Carolina
28405 applied to be registered as an
importer of the following basic classes
of controlled substances:
SUPPLEMENTARY INFORMATION:
[Docket No. DEA–392]
Importer of Controlled Substances
Application: Alcami Carolinas
Corporation
ACTION:
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for a
hearing should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
Notice of application.
under 21 U.S.C. 952(a)(2). Authorization
will not extend to the import of FDA
approved or non-approved finished
dosage forms for commercial sale.
Dated: July 16, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019–16164 Filed 7–29–19; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Registration
ACTION:
Notice of registration.
The registrant listed below
has applied for and been granted
registration by the Drug Enforcement
Administration (DEA) as an importer of
schedule I or schedule II controlled
substances.
SUMMARY:
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before August 29, 2019. Such persons
may also file a written request for a
hearing on the application on or before
August 29, 2019.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
DATES:
Drug
code
Controlled substance
Psilocybin .................
Psilocyn ....................
Thebaine ...................
Pentobarbital ............
7437
7438
9333
2270
Schedule
I
I
II
II
The company plans to import the
listed controlled substances in bulk for
the manufacturing of capsules/tablets
for Phase II clinical trials. Approval of
permit applications will occur only
when the registrant’s activity is
consistent with what is authorized
SUPPLEMENTARY INFORMATION:
The company listed below applied to
be registered as an importer of various
basic classes of controlled substances.
Information on the previously published
notice is listed in the table below. No
comments or objections were submitted
and no requests for a hearing were
submitted for this notice.
Company
FR docket
jspears on DSK3GMQ082PROD with NOTICES
AndersonBrecon, Inc ............................................................................................................................................
The DEA has considered the factors in
21 U.S.C. 823, 952(a) and 958(a) and
determined that the registration of the
listed registrant to import the applicable
basic classes of schedule I or II
controlled substances is consistent with
the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971. The DEA
investigated the company’s maintenance
of effective controls against diversion by
inspecting and testing the company’s
physical security systems, verifying the
company’s compliance with state and
local laws, and reviewing the company’s
background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the DEA has
granted a registration as an importer for
schedule I controlled substances to the
above listed company.
VerDate Sep<11>2014
16:42 Jul 29, 2019
Jkt 247001
Dated: July 16, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019–16169 Filed 7–29–19; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Application: Research Triangle
Institute
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before August 29, 2019. Such persons
may also file a written request for a
DATES:
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
84 FR 21813
Published
May 15, 2019.
hearing on the application on or before
August 29, 2019.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for a
hearing should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION:
In accordance with 21 CFR
1301.34(a), this is notice that on May 03,
2019, Research Triangle Institute, 3040
East Cornwallis Road, Hermann
E:\FR\FM\30JYN1.SGM
30JYN1
]]>Agencies
[Federal Register Volume 84, Number 146 (Tuesday, July 30, 2019)]
[Notices]
[Pages 36937-36941]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-16176]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Application: Chemtos,
LLC
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration on or before September 30, 2019.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DRW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on May 15, 2019, Chemtos, LLC, 16713 Picadilly Court,
Round Rock, Texas 78664-8544 applied to be registered as a bulk
manufacturer of the following basic classes of controlled substances:
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
3-Fluoro-N-methylcathinone (3- 1233 I
FMC).
Cathinone........................ 1235 I
Methcathinone.................... 1237 I
4-Fluoro-N-methylcathinone (4- 1238 I
FMC).
Pentedrone ([alpha]- 1246 I
methylaminovalerophenone).
Mephedrone (4-Methyl-N- 1248 I
methylcathinone).
4-Methyl-N-ethylcathinone (4-MEC) 1249 I
Naphyrone........................ 1258 I
N-Ethylamphetamine............... 1475 I
N,N-Dimethylamphetamine.......... 1480 I
Fenethylline..................... 1503 I
Aminorex......................... 1585 I
4-Methylaminorex (cis isomer).... 1590 I
Gamma Hydroxybutyric Acid........ 2010 I
Methaqualone..................... 2565 I
Mecloqualone..................... 2572 I
JWH-250 (1-Pentyl-3-(2- 6250 I
methoxyphenylacetyl) indole).
SR-18 (Also known as RCS-8) (1- 7008 I
Cyclohexylethyl-3-(2-
methoxyphenylacetyl) indole).
ADB-FUBINACA (N-(1-amino-3,3- 7010 I
dimethyl-1-oxobutan-2-yl)-1-(4-
fluorobenzyl)-1H-indazole-3-
carboxamide).
5-Fluoro-UR-144 and XLR11 [1-(5- 7011 I
Fluoro-pentyl)1H-indol-3-
yl](2,2,3,3-
tetramethylcyclopropyl)methanone.
AB-FUBINACA (N-(1-amino-3-methyl- 7012 I
1-oxobutan-2-yl)-1-(4-
fluorobenzyl)-1H-indazole-3-
carboxamide).
JWH-019 (1-Hexyl-3-(1- 7019 I
naphthoyl)indole).
MDMB-FUBINACA (Methyl 2-(1-(4- 7020 I
fluorobenzyl)-1H-indazole-3-
carboxamido)-3,3-
dimethylbutanoate).
AB-PINACA (N-(1-amino-3-methyl-1- 7023 I
oxobutan-2-yl)-1-pentyl-1H-
indazole-3-carboxamide).
THJ-2201 [1-(5-fluoropentyl)-1H- 7024 I
indazol-3-yl](naphthalen-1-
yl)methanone.
AB-CHMINACA (N-(1-amino-3-methyl- 7031 I
1-oxobutan-2-yl)-1-
(cyclohexylmethyl)-1H-indazole-3-
carboxamide.
MAB-CHMINACA (N-(1-amino- 7032 I
3,3dimethyl-1-oxobutan-2-yl)-1-
(cyclohexylmethyl)-1H-indazole-3-
carboxamide).
5F-AMB (Methyl 2-(1-(5- 7033 I
fluoropentyl)-1H-indazole-3-
carboxamido)-3-methylbutanoate).
5F-ADB; 5F-MDMB-PINACA (Methyl 2- 7034 I
(1-(5-fluoropentyl)-1H-indazole-
3-carboxamido)-3,3-
dimethylbutanoate).
ADB-PINACA (N-(1-amino-3,3- 7035 I
dimethyl-1-oxobutan-2-yl)-1-
pentyl-1H-indazole-3-
carboxamide).
MDMB-CHMICA, MMB-CHMINACA (Methyl 7042 I
2-(1-(cyclohexylmethyl)-1H-
indole-3-carboxamido)-3,3-
dimethylbutanoate).
APINACA and AKB48 N-(1-Adamantyl)- 7048 I
1-pentyl-1H-indazole-3-
carboxamide.
5F-APINACA, 5F-AKB48 (N- 7049 I
(adamantan-1-yl)-1-(5-
fluoropentyl)-1H-indazole-3-
carboxamide).
JWH-081 (1-Pentyl-3-(1-(4- 7081 I
methoxynaphthoyl) indole).
SR-19 (Also known as RCS-4) (1- 7104 I
Pentyl-3-[(4-methoxy)-benzoyl]
indole.
JWH-018 (also known as AM678) (1- 7118 I
Pentyl-3-(1-naphthoyl)indole).
JWH-122 (1-Pentyl-3-(4-methyl-1- 7122 I
naphthoyl) indole).
[[Page 36938]]
UR-144 (1-Pentyl-1H-indol-3- 7144 I
yl)(2,2,3,3-
tetramethylcyclopropyl)methanone.
JWH-073 (1-Butyl-3-(1- 7173 I
naphthoyl)indole).
JWH-200 (1-[2-(4- 7200 I
Morpholinyl)ethyl]-3-(1-
naphthoyl)indole).
AM2201 (1-(5-Fluoropentyl)-3-(1- 7201 I
naphthoyl) indole).
JWH-203 (1-Pentyl-3-(2- 7203 I
chlorophenylacetyl) indole).
PB-22 (Quinolin-8-yl 1-pentyl-1H- 7222 I
indole-3-carboxylate).
5F-PB-22 (Quinolin-8-yl 1-(5- 7225 I
fluoropentyl)-1H-indole-3-
carboxylate).
Alpha-ethyltryptamine............ 7249 I
Ibogaine......................... 7260 I
CP-47,497 (5-(1,1-Dimethylheptyl)- 7297 I
2-[(1R,3S)-3-hydroxycyclohexyl-
phenol).
CP-47,497 C8 Homologue (5-(1,1- 7298 I
Dimethyloctyl)-2-[(1R,3S)3-
hydroxycyclohexyl-phenol).
Lysergic acid diethylamide....... 7315 I
2,5-Dimethoxy-4-(n)- 7348 I
propylthiophenethylamine (2C-T-
7).
Marihuana Extract................ 7350 I
Marihuana........................ 7360 I
Parahexyl........................ 7374 I
Mescaline........................ 7381 I
2-(4-Ethylthio-2,5- 7385 I
dimethoxyphenyl) ethanamine (2C-
T-2 ).
3,4,5-Trimethoxyamphetamine...... 7390 I
4-Bromo-2,5-dimethoxyamphetamine. 7391 I
4-Bromo-2,5- 7392 I
dimethoxyphenethylamine.
4-Methyl-2,5-dimethoxyamphetamine 7395 I
2,5-Dimethoxyamphetamine......... 7396 I
JWH-398 (1-Pentyl-3-(4-chloro-1- 7398 I
naphthoyl) indole).
2,5-Dimethoxy-4-ethylamphetamine. 7399 I
3,4-Methylenedioxyamphetamine.... 7400 I
5-Methoxy-3,4- 7401 I
methylenedioxyamphetamine.
N-Hydroxy-3,4- 7402 I
methylenedioxyamphetamine.
3,4-Methylenedioxy-N- 7404 I
ethylamphetamine.
3,4-Methylenedioxymethamphetamine 7405 I
4-Methoxyamphetamine............. 7411 I
5-Methoxy-N-N-dimethyltryptamine. 7431 I
Alpha-methyltryptamine........... 7432 I
Bufotenine....................... 7433 I
Diethyltryptamine................ 7434 I
Dimethyltryptamine............... 7435 I
Psilocybin....................... 7437 I
Psilocyn......................... 7438 I
5-Methoxy-N,N- 7439 I
diisopropyltryptamine.
N-Ethyl-1-phenylcyclohexylamine.. 7455 I
1-(1-Phenylcyclohexyl)pyrrolidine 7458 I
1-[1-(2- 7470 I
Thienyl)cyclohexyl]piperidine.
1-[1-(2- 7473 I
Thienyl)cyclohexyl]pyrrolidine.
N-Ethyl-3-piperidyl benzilate.... 7482 I
N-Methyl-3-piperidyl benzilate... 7484 I
N-Benzylpiperazine............... 7493 I
4-Methyl- 7498 I
alphapyrrolidinopropiophenone (4-
MePPP).
2-(2,5-Dimethoxy-4-methylphenyl) 7508 I
ethanamine (2C-D).
2-(2,5-Dimethoxy-4-ethylphenyl) 7509 I
ethanamine (2C-E ).
2-(2,5-Dimethoxyphenyl) 7517 I
ethanamine (2C-H).
2-(4-iodo-2,5-dimethoxyphenyl) 7518 I
ethanamine (2C-I).
2-(4-Chloro-2,5-dimethoxyphenyl) 7519 I
ethanamine (2C-C).
2-(2,5-Dimethoxy-4-nitro-phenyl) 7521 I
ethanamine (2C-N).
2-(2,5-Dimethoxy-4-(n)- 7524 I
propylphenyl) ethanamine (2C-P).
2-(4-Isopropylthio)-2,5- 7532 I
dimethoxyphenyl) ethanamine (2C-
T-4).
MDPV (3,4- 7535 I
Methylenedioxypyrovalerone).
2-(4-bromo-2,5-dimethoxyphenyl)-N- 7536 I
(2-methoxybenzyl) ethanamine
(25B-NBOMe).
2-(4-chloro-2,5-dimethoxyphenyl)- 7537 I
N-(2-methoxybenzyl) ethanamine
(25C-NBOMe).
2-(4-iodo-2,5-dimethoxyphenyl)-N- 7538 I
(2-methoxybenzyl) ethanamine
(25I-NBOMe).
Methylone (3,4-Methylenedioxy-N- 7540 I
methylcathinone).
Butylone......................... 7541 I
Pentylone........................ 7542 I
alpha-pyrrolidinopentiophenone 7545 I
([alpha]-PVP).
alpha-pyrrolidinobutiophenone 7546 I
([alpha]-PBP).
AM-694 (1-(5-Fluoropentyl)-3-(2- 7694 I
iodobenzoyl) indole).
Acetyldihydrocodeine............. 9051 I
Benzylmorphine................... 9052 I
Codeine-N-oxide.................. 9053 I
Cyprenorphine.................... 9054 I
Desomorphine..................... 9055 I
Etorphine (except HCl)........... 9056 I
Codeine methylbromide............ 9070 I
Dihydromorphine.................. 9145 I
Difenoxin........................ 9168 I
[[Page 36939]]
Heroin........................... 9200 I
Hydromorphinol................... 9301 I
Methyldesorphine................. 9302 I
Methyldihydromorphine............ 9304 I
Morphine methylbromide........... 9305 I
Morphine methylsulfonate......... 9306 I
Morphine-N-oxide................. 9307 I
Myrophine........................ 9308 I
Nicocodeine...................... 9309 I
Nicomorphine..................... 9312 I
Normorphine...................... 9313 I
Pholcodine....................... 9314 I
Thebacon......................... 9315 I
Acetorphine...................... 9319 I
Drotebanol....................... 9335 I
U-47700 (3,4-dichloro-N-[2- 9547 I
(dimethylamino)cyclohexyl]-N-
methylbenzamide).
AH-7921 (3,4-dichloro-N-[(1- 9551 I
dimethylamino)cyclohexylmethyl]b
enzamide)).
Acetylmethadol................... 9601 I
Allylprodine..................... 9602 I
Alphacetylmethadol except levo- 9603 I
alphacetylmethadol.
Alphameprodine................... 9604 I
Alphamethadol.................... 9605 I
Benzethidine..................... 9606 I
Betacetylmethadol................ 9607 I
Betameprodine.................... 9608 I
Betamethadol..................... 9609 I
Betaprodine...................... 9611 I
Clonitazene...................... 9612 I
Dextromoramide................... 9613 I
Diampromide...................... 9615 I
Diethylthiambutene............... 9616 I
Dimenoxadol...................... 9617 I
Dimepheptanol.................... 9618 I
Dimethylthiambutene.............. 9619 I
Dioxaphetyl butyrate............. 9621 I
Dipipanone....................... 9622 I
Ethylmethylthiambutene........... 9623 I
Etonitazene...................... 9624 I
Etoxeridine...................... 9625 I
Furethidine...................... 9626 I
Hydroxypethidine................. 9627 I
Ketobemidone..................... 9628 I
Levomoramide..................... 9629 I
Levophenacylmorphan.............. 9631 I
Morpheridine..................... 9632 I
Noracymethadol................... 9633 I
Norlevorphanol................... 9634 I
Normethadone..................... 9635 I
Norpipanone...................... 9636 I
Phenadoxone...................... 9637 I
Phenampromide.................... 9638 I
Phenoperidine.................... 9641 I
Piritramide...................... 9642 I
Proheptazine..................... 9643 I
Properidine...................... 9644 I
Racemoramide..................... 9645 I
Trimeperidine.................... 9646 I
Phenomorphan..................... 9647 I
Propiram......................... 9649 I
1-Methyl-4-phenyl-4- 9661 I
propionoxypiperidine.
1-(2-Phenylethyl)-4-phenyl-4- 9663 I
acetoxypiperidine.
Tilidine......................... 9750 I
Acryl fentanyl (N-(1- 9811 I
phenethylpiperidin-4-yl)-N-
phenylacrylamide).
Para-Fluorofentanyl.............. 9812 I
3-Methylfentanyl................. 9813 I
Alpha-methylfentanyl............. 9814 I
Acetyl-alpha-methylfentanyl...... 9815 I
Acetyl Fentanyl (N-(1- 9821 I
phenethylpiperidin-4-yl)-N-
phenylacetamide).
Butyryl Fentanyl................. 9822 I
4-Fluoroisobutyryl fentanyl (N-(4- 9824 I
fluorophenyl)-N-(1-
phenethylpiperidin-4-
yl)isobutyramide).
Beta-hydroxyfentanyl............. 9830 I
Beta-hydroxy-3-methylfentanyl.... 9831 I
Alpha-methylthiofentanyl......... 9832 I
3-Methylthiofentanyl............. 9833 I
[[Page 36940]]
Furanyl fentanyl (N-(1- 9834 I
phenethylpiperidin-4-yl)-N-
phenylfuran-2-carboxamide).
Thiofentanyl..................... 9835 I
Beta-hydroxythiofentanyl......... 9836 I
Amphetamine...................... 1100 II
Methamphetamine.................. 1105 II
Lisdexamfetamine................. 1205 II
Phenmetrazine.................... 1631 II
Methylphenidate.................. 1724 II
Amobarbital...................... 2125 II
Pentobarbital.................... 2270 II
Secobarbital..................... 2315 II
Glutethimide..................... 2550 II
Nabilone......................... 7379 II
1-Phenylcyclohexylamine.......... 7460 II
Phencyclidine.................... 7471 II
4-Anilino-N-phenethyl-4- 8333 II
piperidine (ANPP).
Phenylacetone.................... 8501 II
1- 8603 II
Piperidinocyclohexanecarbonitril
e.
Alphaprodine..................... 9010 II
Anileridine...................... 9020 II
Cocaine.......................... 9041 II
Codeine.......................... 9050 II
Etorphine HCl.................... 9059 II
Dihydrocodeine................... 9120 II
Oxycodone........................ 9143 II
Hydromorphone.................... 9150 II
Diphenoxylate.................... 9170 II
Ecgonine......................... 9180 II
Ethylmorphine.................... 9190 II
Hydrocodone...................... 9193 II
Levomethorphan................... 9210 II
Levorphanol...................... 9220 II
Isomethadone..................... 9226 II
Meperidine....................... 9230 II
Meperidine intermediate-A........ 9232 II
Meperidine intermediate-B........ 9233 II
Meperidine intermediate-C........ 9234 II
Methadone........................ 9250 II
Methadone intermediate........... 9254 II
Metopon.......................... 9260 II
Dextropropoxyphene, bulk (non- 9273 II
dosage forms).
Morphine......................... 9300 II
Thebaine......................... 9333 II
Dihydroetorphine................. 9334 II
Levo-alphacetylmethadol.......... 9648 II
Oxymorphone...................... 9652 II
Noroxymorphone................... 9668 II
Phenazocine...................... 9715 II
Thiafentanil..................... 9729 II
Piminodine....................... 9730 II
Racemethorphan................... 9732 II
Racemorphan...................... 9733 II
Alfentanil....................... 9737 II
Remifentanil..................... 9739 II
Sufentanil....................... 9740 II
Carfentanil...................... 9743 II
Tapentadol....................... 9780 II
Bezitramide...................... 9800 II
Fentanyl......................... 9801 II
Moramide-intermediate............ 9802 II
------------------------------------------------------------------------
[[Page 36941]]
The company plans to manufacture small quantities of the listed
controlled substances in bulk for distribution to its customers.
Dated: July 16, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019-16176 Filed 7-29-19; 8:45 am]
BILLING CODE 4410-09-P
